| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Chen-Jee Hong, Younger W-Y Yu, Ching-Hua Lin, Shih-Jen Tsa. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neuroscience letters. vol 349. issue 3. 2003-12-04. PMID:12951204. |
our finding suggests that this bdnf-gene val66met polymorphism may be related to schizophrenia pathogenesis in patients responsive to clozapine treatment. |
2003-12-04 |
2023-08-12 |
Not clear |
| Peter Schult. What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia. Clinical pharmacokinetics. vol 42. issue 7. 2003-11-25. PMID:12844323. |
clozapine is the gold standard and 'last resort' in treatment of refractory schizophrenia. |
2003-11-25 |
2023-08-12 |
Not clear |
| M Mazza, C Tozzini, P Giosué, A De Risio, M Palmucci, R Roncone, M Casacchi. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study]. La Clinica terapeutica. vol 154. issue 2. 2003-11-24. PMID:12856365. |
our study was conducted in the form of naturalistic observation of a sample of 45 people affected by schizophrenia treated with haloperidol, clozapine and risperidone. |
2003-11-24 |
2023-08-12 |
Not clear |
| Stephen J Glatt, Stephen V Faraone, Ming T Tsuan. Schizophrenia is not associated with DRD4 48-base-pair-repeat length or individual alleles: results of a meta-analysis. Biological psychiatry. vol 54. issue 6. 2003-11-10. PMID:13129658. |
the gene drd4, coding for dopamine receptor d4, was considered a candidate for association with schizophrenia based on its upregulation in postmortem schizophrenic brain and affinity for clozapine. |
2003-11-10 |
2023-08-12 |
Not clear |
| Joyce G Small, Marietta H Klapper, Frederick W Malloy, Timothy M Steadma. Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder. Journal of clinical psychopharmacology. vol 23. issue 3. 2003-10-23. PMID:12826983. |
tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder. |
2003-10-23 |
2023-08-12 |
Not clear |
| Berna Binnur Kivircik, Köksal Alptekin, Sezer Calişkan, Abdurrahman Cömlekçi, Gonca Orük, Mevhibe Tümüklü, Kablan Kürklü, Haluk Arkar, Ayşe Türk, Mehmet Calişkan, Sena Yeşi. Effect of clozapine on serum leptin, insulin levels, and body weight and composition in patients with schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 27. issue 5. 2003-10-23. PMID:12921912. |
effect of clozapine on serum leptin, insulin levels, and body weight and composition in patients with schizophrenia. |
2003-10-23 |
2023-08-12 |
Not clear |
| M A Tanner, W Cullin. Clozapine associated dilated cardiomyopathy. Postgraduate medical journal. vol 79. issue 933. 2003-10-09. PMID:12897222. |
his only significant past medical history was of chronic schizophrenia for which he had been taking clozapine for six years. |
2003-10-09 |
2023-08-12 |
Not clear |
| Joanna Moncrief. Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. The British journal of psychiatry : the journal of mental science. vol 183. 2003-09-30. PMID:12893670. |
clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. |
2003-09-30 |
2023-08-12 |
Not clear |
| Christopher D Carlson, Patrizia A Cavazzoni, Paul H Berg, Hank Wei, Charles M Beasley, John M Kan. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine. The Journal of clinical psychiatry. vol 64. issue 8. 2003-09-25. PMID:12927004. |
an integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine. |
2003-09-25 |
2023-08-12 |
Not clear |
| Baruch Spivak, Evgeny Shabash, Brian Sheitman, Abraham Weizman, Roberto Meste. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. The Journal of clinical psychiatry. vol 64. issue 7. 2003-09-23. PMID:12934974. |
the effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. |
2003-09-23 |
2023-08-12 |
Not clear |
| Jan Volavk. Clozapine may be more effective than olanzapine for reducing suicidal behaviour in people with schizophrenia at high risk. Evidence-based mental health. vol 6. issue 3. 2003-09-15. PMID:12893804. |
clozapine may be more effective than olanzapine for reducing suicidal behaviour in people with schizophrenia at high risk. |
2003-09-15 |
2023-08-12 |
Not clear |
| Thomas J Raedler, Michael B Knable, Douglas W Jones, Richard A Urbina, Michael F Egan, Daniel R Weinberge. Central muscarinic acetylcholine receptor availability in patients treated with clozapine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 28. issue 8. 2003-09-12. PMID:12799613. |
eight schizophrenia patients underwent a total of 12 [i-123]iqnb spect scans after treatment with low to moderate doses of clozapine (mean 210 mg/day, range 50-450 mg/day). |
2003-09-12 |
2023-08-12 |
human |
| Margaret G Woerner, Delbert G Robinson, Jose Ma J Alvir, Brian B Sheitman, Jeffrey A Lieberman, John M Kan. Clozapine as a first treatment for schizophrenia. The American journal of psychiatry. vol 160. issue 8. 2003-09-05. PMID:12900316. |
clozapine as a first treatment for schizophrenia. |
2003-09-05 |
2023-08-12 |
Not clear |
| Margaret G Woerner, Delbert G Robinson, Jose Ma J Alvir, Brian B Sheitman, Jeffrey A Lieberman, John M Kan. Clozapine as a first treatment for schizophrenia. The American journal of psychiatry. vol 160. issue 8. 2003-09-05. PMID:12900316. |
the authors' goal was to explore whether clozapine given as the first antipsychotic treatment favorably affects the course of schizophrenia. |
2003-09-05 |
2023-08-12 |
Not clear |
| D Cohen, C C Gispen-de Wie. [Schizophrenia and diabetes mellitus: not an improbable combination]. Nederlands tijdschrift voor geneeskunde. vol 147. issue 21. 2003-08-06. PMID:12811967. |
three male schizophrenia patients, aged 41, 40 and 61 years respectively, who had undergone treatment without a satisfactory result, were treated with the antipsychotic clozapine. |
2003-08-06 |
2023-08-12 |
Not clear |
| Shailesh Kumar, Bradley Ng, William Howi. The improvement of obsessive- compulsive symptoms in a patient with schizophrenia treated with clozapine. Psychiatry and clinical neurosciences. vol 57. issue 2. 2003-07-28. PMID:12667173. |
the improvement of obsessive- compulsive symptoms in a patient with schizophrenia treated with clozapine. |
2003-07-28 |
2023-08-12 |
Not clear |
| David Pickar, John J Bartk. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia. The American journal of psychiatry. vol 160. issue 6. 2003-07-23. PMID:12777272. |
effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia. |
2003-07-23 |
2023-08-12 |
Not clear |
| Christian Haasen, Martin Lambert, Oktay Yagdiran, Anne Karow, Michael Krausz, Dieter Nabe. Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain. International clinical psychopharmacology. vol 18. issue 2. 2003-07-15. PMID:12598824. |
comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain. |
2003-07-15 |
2023-08-12 |
Not clear |
| Christian Haasen, Martin Lambert, Oktay Yagdiran, Anne Karow, Michael Krausz, Dieter Nabe. Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain. International clinical psychopharmacology. vol 18. issue 2. 2003-07-15. PMID:12598824. |
our unique case report of a patient with comorbid galactosemia and schizophrenia is an interesting example of weight gain being a positive side-effect of clozapine, not necessarily associated with increased appetite and higher caloric intake. |
2003-07-15 |
2023-08-12 |
Not clear |
| Adrienne C Lahti, Henry H Holcomb, Martin A Weiler, Deborah R Medoff, Carol A Tamming. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biological psychiatry. vol 53. issue 7. 2003-07-11. PMID:12679238. |
using positron emission tomography (pet) with (15)o water, we compared regional cerebral blood flow (rcbf) patterns induced by clozapine or haloperidol in individuals with schizophrenia. |
2003-07-11 |
2023-08-12 |
Not clear |